You are here: Industry Insights > Vaccine

News List

Virus-like particle vaccine protects against RSV vaccine-enhanced respiratory disease europeanpharmaceuticalreview
November 27, 2017
Researchers have discovered that a virus-like particle vaccine can prime the body’s immune response and prevent the severe respiratory diseases…
Merck will delay filing Ebola vaccine for approval until 2018, company confirms fiercepharma
November 22, 2017
Despite a frantic effort to rush Ebola vaccines through testing during a deadly epidemic, Merck & Co. will fall short of its goal to file its candidate for FDA approval this year, the company confirmed Tuesday.
FDA clears first new hep B vaccine in 25 years pharmatimes
November 14, 2017
The US Food and Drug Administration is allowing onto the market the first new hepatitis B vaccine in more than 25 years with the approval of Dynavax’ Heplisav-B.
Researchers design a vaccine for Streptococcus biospectrumasia
November 07, 2017
The researchers say that a vaccine which was 80% effective and reached 90% of women could potentially prevent 231,000 infant and maternal cases of disease.
4-in-1 vaccine may provide lifelong protection against influenza europeanpharmaceuticalreview
November 06, 2017
A vaccine combining centralised ancestral genes from four major influenza strains appears to provide broad protection against influenza…
China approves domestic Ebola vaccine biospectrumasia
October 27, 2017
The newly approved vaccine is superior to the currently available vaccines in terms of the stability.
GSK's shingles vaccine scores US approval pharmafile
October 24, 2017
GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention of the disease in patients aged 50 or older.
New vaccine offers hope for pneumonia europeanpharmaceuticalreview
October 23, 2017
Scientists are developing a vaccine by targeting strains of S. pneumoniae…
Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership pharmafile
October 20, 2017
Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to develop and commercialise up to five cancer vaccine products.
GlaxoSmithKline wins first-ever nod for blockbuster vaccine prospect Shingrix fiercepharma
October 18, 2017
The Canadian approval covers people 50 years or older, as a prevention tool against the painful condition that's caused by latent varicella infection.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 99 100 Next page